{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T17:04:04Z","timestamp":1781283844119,"version":"3.54.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.neurol.2026.03.002","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T12:11:53Z","timestamp":1774267913000},"page":"489-492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u201cTime is Brain\u201d also in multiple sclerosis: Fifteen years later, a fully consolidated concept"],"prefix":"10.1016","volume":"182","author":[{"given":"A.","family":"Maarouf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Audoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.neurol.2026.03.002_bib0135","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1177\/1352458509345920","article-title":"Time is brain also in multiple sclerosis","volume":"15","author":"Frydman","year":"2009","journal-title":"Mult Scler"},{"issue":"10","key":"10.1016\/j.neurol.2026.03.002_bib0140","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S1474-4422(25)00270-4","article-title":"2024 revisions of the McDonald criteria","volume":"24","author":"Montalban","year":"2025","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1016\/j.neurol.2026.03.002_bib0145","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41582-022-00686-x","article-title":"From the prodromal stage of multiple sclerosis to disease prevention","volume":"18","author":"Marrie","year":"2022","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"10.1016\/j.neurol.2026.03.002_bib0150","doi-asserted-by":"crossref","first-page":"e2524635","DOI":"10.1001\/jamanetworkopen.2025.24635","article-title":"Health care use before multiple sclerosis symptom onset","volume":"8","author":"Ruiz-Alguer\u00f3","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.neurol.2026.03.002_bib0155","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaf180","article-title":"Higher healthcare use before paediatric multiple sclerosis onset: a nationwide cohort study","volume":"7","author":"McKay","year":"2025","journal-title":"Brain Commun"},{"issue":"1","key":"10.1016\/j.neurol.2026.03.002_bib0160","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jamaneurol.2019.3238","article-title":"Serum neurofilament light chain levels in patients with presymptomatic multiple sclerosis","volume":"77","author":"Bjornevik","year":"2020","journal-title":"JAMA Neurol"},{"issue":"6578","key":"10.1016\/j.neurol.2026.03.002_bib0165","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.neurol.2026.03.002_bib0170","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1093\/brain\/awad073","article-title":"The radiologically isolated syndrome: revised diagnostic criteria","volume":"146","author":"Lebrun-Fr\u00e9nay","year":"2023","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.neurol.2026.03.002_bib0175","doi-asserted-by":"crossref","first-page":"e2128271","DOI":"10.1001\/jamanetworkopen.2021.28271","article-title":"Risk factors and time to clinical symptoms of multiple sclerosis among patients with radiologically isolated syndrome","volume":"4","author":"Lebrun-Fr\u00e9nay","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.neurol.2026.03.002_bib0180","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(22)00009-6","article-title":"Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study","volume":"21","author":"Benkert","year":"2022","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1016\/j.neurol.2026.03.002_bib0185","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S1474-4422(25)00304-7","article-title":"2024 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI for the diagnosis of multiple sclerosis","volume":"24","author":"Barkhof","year":"2025","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1016\/j.neurol.2026.03.002_bib0190","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/RLI.0000000000001082","article-title":"Cortical lesions as an early hallmark of multiple sclerosis: visualization by 7T MRI","volume":"59","author":"Durozard","year":"2024","journal-title":"Invest Radiol"},{"key":"10.1016\/j.neurol.2026.03.002_bib0195","doi-asserted-by":"crossref","first-page":"104573","DOI":"10.1016\/j.ebiom.2023.104573","article-title":"Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity-a cohort study","volume":"91","author":"Hegen","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.neurol.2026.03.002_bib0200","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S1474-4422(21)00063-6","article-title":"Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances","volume":"20","author":"Bar-Or","year":"2021","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2026.03.002_bib0205","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41591-025-04014-w","article-title":"Myelin injury precedes axonal injury and symptomatic onset in multiple sclerosis","volume":"32","author":"Abdelhak","year":"2026","journal-title":"Nat Med"},{"key":"10.1016\/j.neurol.2026.03.002_bib0210","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/jamaneurol.2018.4905","article-title":"Clinical outcomes of escalation vs early intensive disease-modifying therapy in patients with multiple sclerosis","volume":"76","author":"Harding","year":"2019","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.1016\/j.neurol.2026.03.002_bib0215","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1474-4422(20)30067-3","article-title":"Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study","volume":"19","author":"He","year":"2020","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1016\/j.neurol.2026.03.002_bib0220","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jamaneurol.2021.2738","article-title":"Treatment escalation vs immediate initiation of highly effective treatment for patients with relapsing-remitting multiple sclerosis: data from 2 different national strategies","volume":"78","author":"Spelman","year":"2021","journal-title":"JAMA Neurol"},{"issue":"13","key":"10.1016\/j.neurol.2026.03.002_bib0225","doi-asserted-by":"crossref","first-page":"e1280","DOI":"10.1212\/WNL.0000000000207664","article-title":"Association of very early treatment initiation with the risk of long-term disability in patients with a first demyelinating event","volume":"101","author":"Cobo-Calvo","year":"2023","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurol.2026.03.002_bib0230","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1001\/jamaneurol.2019.3365","article-title":"Infection risks among patients with multiple sclerosis treated with fingolimod, natalizumab, rituximab, and injectable therapies","volume":"77","author":"Luna","year":"2020","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2026.03.002_bib0235","doi-asserted-by":"crossref","first-page":"e200534","DOI":"10.1212\/NXI.0000000000200534","article-title":"Enterovirus encephalitis in people with multiple sclerosis on ocrelizumab: insights from a multicenter case series","volume":"13","author":"Banks","year":"2026","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"10.1016\/j.neurol.2026.03.002_bib0240","doi-asserted-by":"crossref","first-page":"e2319766","DOI":"10.1001\/jamanetworkopen.2023.19766","article-title":"Association between anti-CD20 therapies and COVID-19 severity among patients with relapsing-remitting and progressive multiple sclerosis","volume":"6","author":"Januel","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.neurol.2026.03.002_bib0245","doi-asserted-by":"crossref","first-page":"e00554","DOI":"10.1016\/j.neurot.2025.e00554","article-title":"Extended-interval dosing of rituximab\/ocrelizumab is associated with a reduced decrease in IgG levels in multiple sclerosis","volume":"22","author":"Rigollet","year":"2025","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1016\/j.neurol.2026.03.002_bib0250","doi-asserted-by":"crossref","first-page":"e200152","DOI":"10.1212\/NXI.0000000000200152","article-title":"Efficacy of rituximab outlasts B-cell repopulation in multiple sclerosis: time to rethink dosing?","volume":"10","author":"Claverie","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"10.1016\/j.neurol.2026.03.002_bib0255","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/jnnp-2019-322326","article-title":"Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP)","volume":"91","author":"Butzkueven","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2026.03.002_bib0260","doi-asserted-by":"crossref","first-page":"100470","DOI":"10.1016\/j.bbih.2022.100470","article-title":"Risk of serious infections in multiple sclerosis patients by disease course and disability status: results from a Swedish register-based study","volume":"22","author":"Brand","year":"2022","journal-title":"Brain Behav Immun Health"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378726004807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378726004807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T16:42:10Z","timestamp":1781282530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378726004807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0035378726004807"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2026.03.002","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cTime is Brain\u201d also in multiple sclerosis: Fifteen years later, a fully consolidated concept","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2026.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}